Literature DB >> 12796578

Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve.

Alexander S Rosemurgy1, Emmanuel E Zervos, Mark Bloomston, Alan J Durkin, Whalen C Clark, Stephanie Goff.   

Abstract

OBJECTIVE: To define the role of surgical shunting for patients with poor hepatic reserve (Child's class C) in the era of TIPS. SUMMARY BACKGROUND DATA: Most physicians prefer TIPS to surgical shunting for patients with poor hepatic reserve because of anticipated poor long-term survival.
METHODS: Sixty-two patients of Child's class C with bleeding varices not amenable to endoscopic sclerotherapy or banding were prospectively randomized to undergo TIPS or 8-mm prosthetic H-graft portacaval shunt (HGPCS) from 1993 to 1999. Resource consumption and survival after shunting were determined.
RESULTS: Twenty-nine patients underwent TIPS and 33 underwent HGPCS. After HGPCS, survival at 3 years was favorable but not statistically superior. TIPS was more often associated with shunt stenoses/occlusions, recurrent hemorrhage, shunt revisions, and shunt failure. Long-term follow-up documented that after HGPCS, patients required fewer hospital and ICU days and fewer units of RBCs transfused. After HGPCS, cost of care was less, as was the median cost of care per day of survival.
CONCLUSIONS: For Child's class C patients undergoing HGPCS or TIPS, long-term survival is similar, though favoring HGPCS. Similarly, measures of resource consumption and cost of care following hospital discharge favor HGPCS. HGPCS should be preferentially applied for acceptable patients without access to convenient capable post-shunt care or without definitive plans for imminent transplantation.

Entities:  

Mesh:

Year:  2003        PMID: 12796578      PMCID: PMC1514681          DOI: 10.1097/01.SLA.0000072102.38993.05

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  Use of balloon-expandable stents in transjugular intrahepatic portosystemic shunts in cases of Wallstent endoprosthesis technical failure and revision of shunt stenosis.

Authors:  Chad G Kuhlman; Nilesh H Patel; Matthew S Johnson; Himanshu Shah; Jan Namyslowski; Michael S Stecker; Cynthia S Johnson; Scott O Trerotola
Journal:  J Vasc Interv Radiol       Date:  2002-04       Impact factor: 3.464

2.  TIPS: a therapy to prevent variceal rebleeding in patients listed for liver transplantation.

Authors:  Tadeusz Wróblewski; O Rowiński; B Ziarkiewicz-Wróblewska; B Michałowicz; P Małkowski; J Pawlak; P Nyckowski; M Krawczyk
Journal:  Transplant Proc       Date:  2002-03       Impact factor: 1.066

3.  Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy.

Authors:  A J Sanyal; A M Freedman; V A Luketic; P P Purdum; M L Shiffman; J Tisnado; P E Cole
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

4.  The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts.

Authors:  A J Sanyal; A M Freedman; V A Luketic; P P Purdum; M L Shiffman; J DeMeo; P E Cole; J Tisnado
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

5.  Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial.

Authors:  A S Rosemurgy; F M Serafini; B R Zweibel; T J Black; B T Kudryk; H J Nord; S E Goode
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

Review 6.  Transjugular intrahepatic portal-systemic shunts: the state of the art.

Authors:  H O Conn
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

7.  Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow.

Authors:  E E Zervos; S E Goode; A S Rosemurgy
Journal:  Am Surg       Date:  1998-01       Impact factor: 0.688

8.  A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices.

Authors:  A S Rosemurgy; S E Goode; B R Zwiebel; T J Black; P G Brady
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

9.  The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.

Authors:  M Rössle; K Haag; A Ochs; M Sellinger; G Nöldge; J M Perarnau; E Berger; U Blum; A Gabelmann; K Hauenstein
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

10.  Percutaneous transjugular portosystemic shunt.

Authors:  G Zemel; B T Katzen; G J Becker; J F Benenati; D S Sallee
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

View more
  14 in total

1.  Clinical analysis of surgical treatment of portal hypertension.

Authors:  Xin-Bao Xu; Jing-Xiu Cai; Xi-Sheng Leng; Jia-Hong Dong; Ji-Ye Zhu; Zhen-Ping He; Fu-Shun Wang; Ji-Run Peng; Ben-Li Han; Ru-Yu Du
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

2.  Two surgical procedures for esophagogastric variceal bleeding in patients with portal hypertension.

Authors:  Lin Yang; Li-Juan Yuan; Rui Dong; Ji-Kai Yin; Qing Wang; Tao Li; Jiang-Bin Li; Xi-Lin Du; Jian-Guo Lu
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  [Portosystemic shunt surgery between TIPS and liver transplantation].

Authors:  G Puhl; S Gül; P Neuhaus
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

4.  Current role of surgery in portal hypertension.

Authors:  Sujoy Pal
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

5.  H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals.

Authors:  Alexander S Rosemurgy; Mark Bloomston; Whalen C Clark; Donald P Thometz; Emmanuel E Zervos
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

6.  Extrahepatic portacaval shunt via a magnetic compression technique: A cadaveric feasibility study.

Authors:  Xiao-Peng Yan; Wen-Yan Liu; Jia Ma; Jian-Peng Li; Yi Lv
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

7.  Survival and variceal rehemorrhage after shunting support small-diameter prosthetic H-graft portacaval shunt.

Authors:  Alexander Rosemurgy; Donald Thometz; Whalen Clark; Desiree Villadolid; Elizabeth Carey; Daphne Pinkas; Steven Rakita; Emmanuel Zervos
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.452

8.  Conventional predictors of survival poorly predict and significantly underpredict survival after H-graft portacaval shunts.

Authors:  Sarah M Cowgill; Donald Thometz; Whalen Clark; Desiree Villadolid; Elizabeth Carey; Daphne Pinkas; Emmanuel Zervos; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

9.  Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Danielle Roberts; Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Sivapatham Arunan; Tanjia Begum; Norman R Williams; Dana Walshaw; Elisabeth Jane Milne; Maxine Tapp; Mario Csenar; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-10

10.  Direct costs of care in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt for bleeding esophageal varices in cirrhosis--Part 4.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Kevin S Haynes; Horacio Jinich-Brook; Roderick Rapier; Florin Vaida; Robert J Hye
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.